Vyhláška Ministerstva zdravotnictví, kterou se mění vyhláška Ministerstva zdravotnictví č. 57/1997 Sb., kterou se stanoví léčivé přípravky plně hrazené z veřejného zdravotního pojištění a výše úhrad jednotlivých léčivých látek, ve znění pozdějších předpisů

| 396.8 | N03AX11 | topiramat (do 25 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 169,48 | L/PSY,NEU | | 44671 | TOPAMAX 25MG | tbl obd 28x25mg-bl. | CIL | CH | | | | | 396.9 | N03AX11 | topiramat (nad 25 mg v jedné tabletě) | p.o. | 0.3 | GM | 151,62 | L/PSY,NEU | | 44675 | TOPAMAX 50MG | tbl obd 28x50mg-bl. | CIL | CH | | | | | 44679 | TOPAMAX 100MG | tbl obd 28x100mg-bl | CIL | CH | | | | | 396.10 | N03AX12 | gabapentin | p.o. | 1.8 | GM | 138,23 | L/PSY,NEU | | 84396 | NEURONTIN 100MG | cps 20x100mg | PDA | D | | | | | 84398 | NEURONTIN 100MG | cps 100x100mg | PDA | D | | | | | 84399 | NEURONTIN 300MG | cps 50x300mg | PDA | D | | | | | 84400 | NEURONTIN 300MG | cps 100x300mg | PDA | D | | | | | 84401 | NEURONTIN 400MG | cps 50x400mg | PDA | D | | | | | 84402 | NEURONTIN 400MG | cps 100x400mg | PDA | D | | | | | 397 | N04AA | antiparkinsonika ze skupiny terciárních aminů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 397.1 | NQ4AA | hydrochlorid diethazinia | p.o. | 0.25 | GM | 6,83 | | | 00102 | DEPARKIN | drg 50x50mg | LEX | CZ | | | | | 397.2 | N04AA02 | biperiden | p.o. | 10 | MG | 12,22 | | | | | | | | | | | | 397.3 | N04AA03 | metixen | p.o. | 40 | MG | 18,09 | | | | | | | | | | | | 397.4 | N04AA04 | procyklidin | p.o. | 25 | MG | 8,80 | | | 01337 | KEMADRIN | tbl 100x5mg | BWE | GB | | | | | 398 | N04AA | antiparkinsonika ze skupiny terciárních aminů | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 398.1 | N04AA02 | biperiden | parent. | 10 | MG | 58,52 | O | | 01973 | AKINETON | inj 5x1ml/5mg | EBW | A | | | | | 20056 | AKINETON PRO INFUS. | inj 5x1ml/5mg | KNO | D | | | | | 398.2 | N04AA08 | dexetimid | parent. | 0.12 | MG | 1,71 | O | | 399 | N04AC | antiparkinsonika ze skupiny esterů tropinu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 399.1 | N04AC01 | benzatropin | p.o. | 2 | MG | 3,18 | | | 96751 | APO-BENZTROPINE 2MG | tbl 100x2mg | APT | CND | | | | | 400 | N04BA | antiparkinsonika ze skupiny levodopy a jejích derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 400.1 | N04BA01 | levodopa | p.o. | 3.5 | GM | 24,64 | | | | | | | | | | | | 400.2 | N04BA02 | levodopa/karbidopa (do 125 mg v 1 tabletě včetně) | p.o. | 0.6 | GM | 29,62 | | | 45241 | ISICOM 100MG | tbl 100x100mg | DET | D | | | | | 400.3 | N04BA02 | levodopa/karbidopa (nad 125 mg v 1 tabletě) | p.o. | 0.6 | GM | 19,31 | | | 03591 | NAKOM | tbl 100x275mg | LEK | SLO | | | | | 45244 | ISICOM 250MG | tbl 100x250mg | DET | D | | | | | 400.4 | N04BA02 | levodopa/benserazid | p.o. | 0.6 | GM | 22,00 | | | 12095 | MADOPAR 250 | tbl 30x250mg | LEX | CZ | | | | | 54459 | MADOPAR 250 | tbl 100x250mg | LEX | CZ | | | | | 400.5 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardováné lékové formy do 0,125 GM včetně v jedné tabletě) | p.o. | 0.6 | GM | 32,75 | | | | | | | | | | | | 400.6 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardováné lékové formy nad 0,125 GM v jedné tabletě) | p.o. | 0.6 | GM | 26,69 | | | 401 | N04BB | antiparkinsonika ze skupiny amantadinu a jeho derivátů | p.o. | L/NEU,PSY,GER | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 401.1 | N04BB01 | amantadin hydrochlorid | p.o. | 0.2 | GM | 4,94 | L/NEU,PSY,GER | | 02871 | VIREGYT-K | cps 50x100mg | EGI | H | | | | | 401.2 | N04BB01 | amantadin sulfát | p.o. | 0.2 | GM | 7,33 | L/NEU,PSY,GER | | | | | | | | | | | 401.3 | N04BB01 | amantadin | parent. | 0,2 | GM | 4,25 | H | | 402 | N04BD | antiparkinsonika ze skupiny inhibitorů MAO | p.o. | L/NEU,PSY,GER | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 402.1 | N04BD01 | Selegilin do 5 mg v 1 tabletě včetně | p.o. | 5.0 | MG | 6,35 | L/NEU,PSY,GER | | 31036 | JUMEX 5MG | tbl 50x5mg | CHN | H | | | | | 55764 | COGNITIV 5MG | tbl obd 100x5mg | EBW | A | | | | | 92500 | SEPATREM 5 | tbl 50x5mg | LEX | CZ | | | | | 402.2 | N04BD01 | selegilin nad 5 mg v 1 tabletě | p.o. | 5.0 | MG | 5,85 | L/NEU,PSY,GER | | 92501 | SEPATREM 10 | tbl 50x10mg | LEX | CZ | | | | | 402.3 | N04BX01 | tolkapon | p.o. | 0,3 | GM | 116,72 | X | | | | | | | | | | | 402.4 | N04BC02 | pergolidi mesilas (do 0,05 mg včetně v jedné tabletě) | p.o. | 3 | MG | 176,94 | X | | | | | | | | | | | 402.5 | N04BC03 | dihydroergokriptin | p.o. | 10 | MG | 16,11 | X | | | | | | | | | | | 402.6 | N04BC05 | pramipexol | p.o. | 2,5 | MG | 110,79 | X | | 54412 | MIRAPEXIN 1MG | tbl 100x1mg | PAU | B | | | | | 54410 | MIRAPEXIN 0.25MG | tbl 100x0.25mg | PAU | B | | | | | 54407 | MIRAPEXIN 0.125MG | tbl 30x0.125mg | PAU | B | | | | | 402.7 | N04BC02 | pergolidi mesilas (nad 0,05 mg do 0,25 mg včetně v jedné tabletě) | p.o. | 3 | MG | 145,66 | X | | | | | | | | | | | 402.8 | N04BC02 | pergolidi mesilas (nad 0,25 mg v jedné tabletě) | p.o. | 3 | MG | 132,95 | X | | | | | | | | | | | 402.9 | N04BX02 | entacapon | p.o. | 600 | MG | 116,72 | X | | 54466 | COMTAN | tbl obd 30x200mg | NPA | D | | | | | 402.10 | N04BC04 | ropinirol | p.o. | 6 | MG | 53,17 | X | | 403 | N05AA | neuroleptika ze skupiny dimethylaminopropyl fenothiazinů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 403.1 | N05AA01 | chlorpromazin (pevné lékové formy do 50 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 10,56 | | | 02114 | PLEGOMAZIN | drg 50x25mg | EGI | H | | | | | 403.2 | N05AA01 | chlorpromazin (pevné lékové formy nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 5,67 | | | 62313 | PLEGOMAZIN | drg 30x100mg | EGI | H | | | | | 403.3 | N05AA01 | chlorpromazin (tekuté lékové formy) | p.o. | 0.3 | GM | 62,76 | | | | | | | | | | | | 403.4 | N05AA02 | levomepromazin | p.o. | 0.3 | GM | 14,66 | | | 02429 | TISERCIN | tbl obd 50x25mg | EGI | H | | | | | 403.5 | N05AA03 | promazin | p.o. | 0.3 | GM | 13,49 | | | 404 | N05AA | neuroleptika ze skupiny dimethylaminopropyl fenothiazinů | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 404.1 | N05AA01 | chlorpromazin | parent. | 0.1 | GM | 25,37 | O | | 00560 | PLEGOMAZIN | inj 10x5ml/25mg | EGI | H | | | | | 00561 | PLEGOMAZIN | inj 10x2ml/50mg | EGI | H | | | | | 404.2 | N05AA02 | levomepromazin | parent. | 0.1 | GM | 30,89 | O | | 01845 | TISERCIN | inj 10x1ml/25mg | EGI | H | | | | | 405 | N05AB | neuroleptika ze skupiny piperazinových derivátů fenothiazinu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 405.1 | N05AB03 | perfenazin | p.o. | 30 | MG | 1,76 | | | 00262 | PERFENAZIN LECIVA | tbl obd 50x8mg | LEX | CZ | | | | | 405.2 | N05AB04 | prochlorperazin | p.o. | 0.1 | GM | 12,42 | | | 00274 | PROCHLORPERAZIN LECIVA | tbl 20x10mg | LEX | CZ | | | | | 405.3 | N05AB06 | trifluoperazin | p.o. | 20 | MG | 6,99 | | | | | | | | | | | | 405.4 | N05AB08 | thioproperazin | p.o. | 75 | MG | 6,70 | | | 406 | N05AB | neuroleptika ze skupiny piperazinových derivátů fenothiazinu | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 406.1 | N05AB02 | flufenazin | parent. | 1 | MG | 3,91 | O | | 03514 | MODITEN DEPOT | inj 5x1ml/25mg | BTA | SK | | | | | 407 | N05AC | neuroleptika ze skupiny piperidinových derivátů fenothiazinu | p.o. | L/NEU,PSY,GER | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 407.1 | N05AC01 | periciazin (tekuté lékové formy) | p.o. | 50 | MG | 5,44 | L/NEU,PSY,GER | | 01559 | NEULEPTIL | gtt 1x125ml 4% | RRO | F | | | | | 407.2 | N05AC01 | periciazin (pevné lékové formy) | p.o. | 50 | MG | 5,72 | L/NEU,PSY,GER | | | | | | | | | | | 407.3 | N05AC02 | thioridazin | p.o. | 0.3 | GM | 10,92 | | | 00324 | THIORIDAZIN 25 LECIVA | drg 50x25mg | LEX | CZ | | | | | 00325 | THIORIDAZIN 100 LECIVA | drg 20x100mg | LEX | CZ | | | | | 408 | N05AD | neuroleptika ze skupiny derivátů butyrofenonu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 408.1 | N05AD01 | haloperidol (pevné lékové formy) | p.o. | 8 | MG | 6,06 | | | 67110 | HALOPER 2MG VON CT | tbl 50x2mg | CTA | D | | | | | 67111 | HALOPER 5MG VON CT | tbl 50x5mg | CTA | D | | | | | 67112 | HALOPER 10MG VON CT | tbl 20x10mg | CTA | D | | | | | 67113 | HALOPER 10MG VON CT | tbl 100x10mg | CTA | D | | | | | 98291 | APO-HALOPERIDOL | tbl 100x1mg | APT | CND | | | | | 408.2 | N05AD01 | haloperidol (tekuté lékové formy) | p.o. | 8 | MG | 10,12 | | | 02539 | HALOPERIDOL | gtt 1x10ml/20mg | GED | H | | | | | 408.3 | N05AD02 | trifluperidol (tekuté lékové formy) | p.o. | 2 | MG | 7,72 | | | | | | | | | | | | 408.4 | N05AD02 | trifluperidol (pevné lékové formy) | p.o. | 2 | MG | 3,91 | | | | | | | | | | | | 408.5 | N05AD03 | melperon | p.o. | 0.3 | GM | 24,94 | | | 409 | N05AD | neuroleptika ze skupiny derivátů butyrofenonu | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 409.1 | N05AD01 | haloperidol (depotní lékové formy) | parent. | 3.3 | MG | 8,26 | O | | | | | | | | | | | 409.2 | N05AD01 | haloperidol | parent. | 8 | MG | 16,72 | O | | 02538 | HALOPERIDOL | inj 5x1ml/5mg | GED | H | | | | | 409.3 | N05AD02 | trifluperidol | parent. | 2 | MG | 5,52 | O | | | | | | | | | | | 409.4 | N05AD03 | melperon | parent. | 0.3 | GM | 50,83 | O | | | | | | | | | | | 409.5 | N05AD08 | droperidol | parent. | 25 | MG | 50,83 | O | | 01443 | DEHYDROBENZPERIDOL | inj 50x10ml/25mg | JAN | B | | | | | 410 | N05AF | neuroleptika ze skupiny derivátů thioxanthenu | p o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 410.1 | N05AF | oxyprotepin | p.o. | 20 | MG | 18,28 | | | | | | | | | | | | 410.2 | N05AF01 | flupentixol | p.o. | 6 | MG | 15,70 | | | 88143 | FLUANXOL 1MG | drg 100x1 mg | LUN | DK | | | | | 410.3 | N05AF03 | chlorprothixen (do 5 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 26,39 | | | | | | | | | | | | 410.4 | N05AF03 | chlorprothixen (nad 15 mg v jedné tabletě) | p.o. | 0.3 | GM | 7,82 | | | 75428 | CHLORPROTHIXEN 50 LECIVA | tbl obd 30x50mg | LEX | CZ | | | | | 410.5 | N05AF03 | chlorprothixen (nad 5 do 15 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 12,71 | | | 75433 | CHLORPROTHIXEN 15 LECIVA | tbl obd 30x15mg | LEX | CZ | | | | | 410.6 | N05AF05 | zuklopenthixol | p.o. | 30 | MG | 13,83 | | | 57823 | CISORDINOL 10MG | tbl obd 50x10mg-pp | LUN | DK | | | | | 57827 | CISORDINOL 25MG | tbl obd 50x25mg-pp | LUN | DK | | | | | 411 | N05AF | neuroleptika ze skupiny derivátů thioxanthenu | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 411.1 | N05AF | oxyprotepin | parent. | 1 | MG | 2,44 | O | | 88379 | MECLOPIN | inj 5x1ml/25mg | SPX | CZ | | | | | 411.2 | N05AF01 | flupentixol | parent. | 4 | MG | 15,16 | O | | 91830 | FLUANXOL DEPOT | inj 10x2ml/40mg | LUN | DK | | | | | 411.3 | N05AF03 | chlorprothixen | parent. | 50 | MG | 3,03 | O | | | | | | | | | | | 411.4 | N05AF05 | zuklopenthixol | parent. | 30 | MG | 94,25 | O | | 93252 | CISORDINOL-ACUTARD | inj 10x1ml/50mg | LUN | DK | | | | | 93253 | CISORDINOL-ACUTARD | inj 10x2ml/100mg | LUN | DK | | | | | 411.5 | N05AF05 | zuklopenthixol (depotní formy) | parent. | 15 | MG | 11,78 | O | | 412 | N05AG | neuroleptika ze skupiny difenylbutylpiperidinových derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 412.1 | N05AG02 | pimozid | p.o. | 4 | MG | 10,80 | | | 02757 | ORAP FORTE | tbl 20x4mg | JAN | B | | | | | 98120 | ORAP | tbl 75x1mg | JAN | B | | | | | 412.2 | N05AG03 | penfluridol | p.o. | 6 | MG | 6,11 | | | 09684 | SEMAP | tbl 12x20mg | JAN | B | | | | | 413 | N05AG | neuroleptika ze skupiny difenylbutylpiperidinových derivátů | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 413.1 | N05AG01 | fluspirilen | parent. | 0.7 | MG | 12,71 | O | | 09164 | IMAP | inj 1x6ml/12mg | JAN | B | | | | | 98114 | IMAP | inj 3x1ml/2mg | JAN | B | | | | | 414 | N05AH | neuroleptika ze skupiny dibenzodiazepinů a jejich derivátů | p.o. | L/PSY | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 414.1 | N05AH01 | loxapin | p.o. | 0.1 | GM | 52,20 | L/PSY | | | | | | | | | | | 414.2 | N05AH02 | klozapin (do 25 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 75,03 | L/PSY,NEU | | 03617 | LEPONEX | tbl 50x25mg | SAN | CH | | | | | 414.3 | N05AH02 | klozapin (nad 25 do 50 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 66,18 | L/PSY,NEU | | | | | | | | | | | 414.4 | N05AH02 | klozapin (nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 60,37 | L/PSY | | 02970 | LEPONEX | tbl 50x100mg | SAN | CH | | | | | 414.5 | N05AH03 | olanzapin | p.o. | 10 | MG | 143,00 | L/PSY | | | | | | | | | | | 414.6 | N05AH04 | quetiapin | p.o. | 0.4 | GM | 143,00 | L/PSY | | | | | | | | | | | 414.7 | N05AH | zotepin | p.o. | 0.3 | GM | 76,90 | L/PSY | | 415 | N05AH | neuroleptika ze skupiny dibenzodiazepinů a jejich derivátů | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 415.1 | N05AH02 | klozapin | parent. | 0.3 | GM | 86,22 | H | | 416 | N05AL | neuroleptika ze skupiny benzamidů | p.o. | L/PSY,NEU | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 416.1 | N05AL01 | sulpirid (do 50 mg v jedné tabletě včetně) | p.o. | 0.8 | GM | 42,03 | | | 54432 | PROSULPIN 50 MG | tbl 30x50mg | PMP | CZ | | | | | 416.2 | N05AL01 | Sulpirid (nad 50 mg v jedné tabletě) | p.o. | 0.8 | GM | 24,59 | L/PSY,NEU | | 07387 | PROSULPIN | tbl 30x200mg | PMP | CZ | | | | | 64590 | DOGMATIL 200MG TBL. | tbl 120x200mg | SSJ | F | | | | | 89923 | DOGMATIL 200MG TBL. | tbl 12x200mg | SSJ | F | | | | | 416.3 | N05AL03 | tiaprid (pevné lékové formy) | p.o. | 0.4 | GM | 31,57 | | | | | | | | | | | | 416.4 | N05AL03 | tiaprid (tekuté lékové formy) | p.o. | 0.4 | GM | 46,53 | | | 55695 | TIAPRIDAL | gtt 1x30ml | LSY | F | | | | | 416.5 | N05AL05 | amisulprid (pevné lékové formy) | p.o. | 600 | MG | 119,26 | L/PSY | | 417 | N05AL | neuroleptika ze skupiny benzamidů | parent. | O/PSY,NEU | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 417.1 | N05AL01 | sulpirid | parent. | 0.8 | GM | 74,69 | 0/PSY,NEU | | 89922 | DOGMATIL 100 | inj 6x2ml/100mg | EGJ | F | | | | | 417.2 | N05AL03 | tiaprid | parent. | 0.4 | GM | 55,43 | O | | 91117 | TIAPRIDAL | inj 12x2ml/100mg | LSY | F | | | | | 418 | N05AN | lithium | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 418.1 | N05AN01 | lithium do 0,3 GM včetně v jedné tabletě | p.o. | 1 | GM | 4,84 | | | 02481 | LITHIUM CARBONICUM SLOVAKOFARMA | tbl 100x300mg | SLO | SK | | | | | 418.2 | N05AN01 | lithium nad 0,3 GM v jedné tabletě | p.o. | 1 | GM | 3,23 | | | 04385 | CONTEMNOL | tbl 100x500mg | SLO | SK | | | | | 419 | N05AX | ostatní antipsychotika | p.o. | L/PSY | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 419.1 | N05AX08 | risperidon (pevné lékové formy) | p.o. | 5 | MG | 119,26 | L/PSY | | 46964 | RISPERDAL 1MG | tbl obd 20x1mg | JAG | I | | | | | 46965 | RISPERDAL 1MG | tbl obd 60x1mg | JAG | I | | | | | 46966 | RISPERDAL 2MG | tbl obd 20x2mg | JAG | I | | | | | 46967 | RISPERDAL 2MG | tbl obd 60x2mg | JAG | I | | | | | 46968 | RISPERDAL 3MG | tbl obd 20x3mg | JAG | I | | | | | 46969 | RISPERDAL 3MG | tbl obd 60x3mg | JAG | I | | | | | 46970 | RISPERDAL 4MG | tbl obd 20x4mg | JAG | I | | | | | 46971 | RISPERDAL 4MG | tbl obd 60x4mg | JAG | I | | | | | 419.2 | N05AX08 | risperidon (tekuté lékové formy) | p.o. | 5 | MG | 131,97 | L/INT, PSY, NEU, GER | | | | | | | | | | | 419.3 | N05AE03 | sertindol | p.o. | 1 | DF | 143,12 | L/PSY | | 13039 | SERDOLECT 4MG | tbl obd 30x4mg | LUN | DK | | | | | 419.4 | N05AE04 | ziprasidon | p.o. | 80 | MG | 143,00 | L/PSY | | 420 | N05BA | anxiolytika ze skupiny derivátů benzodiazepinu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu alprazolamem ordinuje psychiatr, neurolog nebo internista: léčba panické úzkosti.

Léčbu hydroxychlorochinem ordinuje infekcionista, revmatolog a dermatolog:

• a) systémový lupus erythematodes,

• b) revmatoidní arthritis,

• c) juvenilní chronická arthritis,

• d) diskoidní forma lupus erythematodes.

Léčbu meflochinem ordinuje infekcionista: léčba tropické malárie (z oblastí s vysokou rezistencí vůči chlorochinu na Plasmodium falciparum).

| 439.1 | P01BA01 | chlorochin | p.o. | 0.5 | GM | 2,42 | | | 00098 | DELAGIL | tbl 30x250mg | IDA | H | | | | | 439.2 | P01BA02 | hydroxychlorochin | p.o. | 0.4 | GM | 18,04 | P | | 01385 | PLAQUENIL | drg 100x200mg | WIN | GB | | | | | 439.3 | P01BA05 | meflochin | p.o. | 1 | GM | 366,98 | P | | 92441 | MEPHAQUIN | tbl obd 6x250mg | MHA | CH | | | | | 440 | P01BD | antimalarika ze skupiny diaminopyrimidinů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 440.1 | P01BD01 | pyrimethamin | p.o. | 75 | MG | 15,93 | | | 02443 | DARAPRIM | tbl 30x25mg | BWE | GB | | | | | 440.2 | P01BD51 | pyrimethamin, kombinace | p.o. | 75 | MG | 50,83 | | | 441 | P01CX | ostatní léčiva k léčbě protozoóz | parent. | X | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 441.1 | P01CX01 | pentamidin isethionát | parent. | 0.28 | GM | 1047,13 | X | | 442 | P02CA | anthelmintika ze skupiny benzimidazolových derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 442.1 | P02CA01 | mebendazol | p.o. | 0.2 | GM | 14,03 | | | 59238 | VERMOX | tbl 6x100mg | JAG | I | | | | | 442.2 | P02CA02 | tiabendazol | p.o. | 3 | GM | 125,42 | | | | | | | | | | | | 442.3 | P02CA03 | albendazol | p.o. | 0.4 | GM | 61,59 | | | 443 | P02CB | anthelmintika ze skupiny piperazinu a jeho derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 443.1 | P02CB01 | piperazin | p.o. | 2 | GM | 3,96 | | | 444 | P02CE | anthelmintika ze skupiny imidazothiazolových derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 444.1 | P02CE01 | levamizol | p.o. | 0.15 | GM | 25,51 | | | 04030 | DECARIS | tbl 2x50mg | GED | H | | | | | 445 | P02CX | ostatní anthelmintika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 445.1 | P02CX01 | pyrvinium | p.o. | 0.3 | GM | 17,69 | | | 02139 | PYRVINIUM | sus 1x100ml | GNO | CZ | | | | | 446 | P02DA | anticestodika ze skupiny derivátů kyseliny salicylové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 446.1 | P02DA01 | niklosamid | p.o. | 2 | GM | 131,19 | | | 02969 | YOMESAN | tbl 4x500mg | BAY | D | | | | | 447 | P03AB | ektoparazitika ze skupiny halogenovaných léčiv | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 447.1 | P03AB02 | lindan (lékové formy gelu) | lok. | 1 | GM | 2,54 | | | | | | | | | | | | 447.2 | P03AB02 | lindan (lékové formy lotia) | lok. | 1 | ML | 1,08 | | | 62365 | JACUTIN | lot 1x1000ml | HEM | D | | | | | 92765 | SKABICID | lot 1x100gm | AVE | CZ | | | | | 97547 | JACUTIN | lot 1x200ml | HEM | D | | | | | 447.3 | P03AB02 | lindan (lékové formy spreje) | lok. | 1 | ML | 1,17 | | | 448 | P03AC | ektoparazitika ze skupiny pyrethrinů | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 448.1 | P03AC | esdepallethrin | lok. | 1 | ML | 1,17 | | | | | | | | | | | | 448.2 | P03AC04 | permerthrin | lok. | 1 | ML | 1,17 | | | 449 | R01AC | protialergická léčiva k lokálnímu podání | lok. | L/ALG,TRN,ORL | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 449.1 | R01AC01 | kyselina kromogliková (do 15 mililitrů včetně v jednom balení) | lok. | 40 | MG | 13,88 | L/ALG,TRN,ORL | | 12582 | ALLERGOCROM | spr nas 1x15ml | URS | D | | | | | 76418 | CROMOBENE | spr nas 1x15ml | MCK | D | | | | | 83652 | CROMOHEXAL | spr nas 1x15ml | HEX | D | | | | | 449.2 | R01AC01 | kyselina kromogliková (nad 15 mililitrů v jednom balení) | lok. | 40 | MG | 13,59 | L/ALG,TRN,ORL | | 86429 | CROMOHEXAL | spr nas 1x30ml | HEX | D | | | | | 449.3 | R01AC02 | levokabastin | lok. | 0.6 | MG | 10,80 | | | | | | | | | | | | 449.4 | R01AC03 | azelastin | lok. | 0.56 | MG | 10,80 | | | 450 | R01AD | kortikosteroidy k lokálnímu podání | lok. | L/ALG,TRN,ORL | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 450.1 | R01AD01 | beclomethason | lok. | 0.4 | MG | 4,30 | | | 66006 | BECLOMET NASAL AQUA | spr nas 23ml/200dav | OKU | SF | | | | | 99860 | BECLOMET NASAL AQUA 100 | aer 23ml 200df | ORN | SF | | | | | 450.2 | R01AD04 | flunisolid | lok. | 0.15 | MG | 7,00 | L/ALG,TRN,ORL | | | | | | | | | | | 450.3 | R01AD05 | budesonid lokálně do 50 RG v jedné dávce včetně | lok. | 0.3 | MG | 7,50 | L/ALG,TRN,ORL | | | | | | | | | | | 450.4 | R01AD05 | budesonid lokálně nad 50 RG v jedné dávce | lok. | 0.3 | MG | 6,75 | L/ALG,TRN,ORL | | | | | | | | | | | 450.5 | R01AD08 | flutikason | lok. | 0.2 | MG | 9,50 | L/ALG,TRN,ORL | | | | | | | | | | | 450.6 | R01AD | triamcinolon acetonid | lok. | 220 | RG | 7,50 | L/ALG,TRN,ORL | | 450.7 | R01AD09 | momethason | lok. | 200 | RG | 10,56 | L/ALG,TRN,ORL | | | | | | | | | | | 450.8 | R01AX03 | ipratropium bromid | lok. | 240 | RG | 8,60 | L/ALG,TRN,ORL | | 451 | R03AC | inhalační selektivní beta-2 sympatomimetika | inhal. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu inhalačního salmeterolu a formoterolu indikuje alergolog a pneumolog u perzistujícího astmatu tam, kde astma není zcela pod kontrolou při podávání kortikosteroidu inhalační cestou a při dobré spolupráci pacienta.

Montelukast s obsahem 5 mg účinné látky v jedné tabletě předepisuje alergolog nebo pneumolog v následujících indikacích u pacientů od 6 do 12 let:

• a) nově diagnostikované nebo nově potvrzené lehké perzistující astma se zřetelnými pozátěžovými příznaky dosud neléčené inhalačními kortikosteroidy

• b) námahou indukované astma

• c) aspirinové astma

Nedojde-li během 3 měsíců léčby ke stabilizaci a kontrole perzistující formy astmatu, není další terapie montelukastem indikována.

U pacientů, kde léčba montelukastem s obsahem 5 mg účinné látky v jedné tabletě byla indikována již před 12 rokem věku a u nichž vykazuje zřetelný efekt, mohou výše uvedení specialisté pokračovat v léčbě až do 14 let věku pacienta.

Léčbu alfadornázou předepisuje ošetřující lékař na doporučení specializovaného pracoviště, které zajišťuje péči o pacienty s cystickou fibrózou, při zajištění dobré spolupráce pacienta:

• a) při nedostatečné účinnosti inhalačních mukolytik nebo amiloridu,

• b) při častých respiračních infekcích vyžadujících antibiotickou léčbu.

Léčbu brimonidinem indikuje oční lékař u pacientů s glaukomem při netoleranci nebo neúčinnosti betablokátorů.

Léčba dorzolamidem včetně kombinací je ordinována v případě neúčinnosti monoterapie betablokátory nebo alfamimetiky nebo v případě netolerance těchto léčiv.